WO2008147468A3 - Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use - Google Patents
Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use Download PDFInfo
- Publication number
- WO2008147468A3 WO2008147468A3 PCT/US2007/087922 US2007087922W WO2008147468A3 WO 2008147468 A3 WO2008147468 A3 WO 2008147468A3 US 2007087922 W US2007087922 W US 2007087922W WO 2008147468 A3 WO2008147468 A3 WO 2008147468A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- virus
- therapeutic agent
- interacting
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Abstract
Layered phyllosilicates are useful for adsorbing and/or binding to and, thereby, inactivating viruses. Accordingly, provided herein are methods of inactivating a virus and methods of treating a viral infection. Methods of delivering a therapeutic agent to a mammalian subject and methods of inactivating a virus in the gastrointestinal tract of an animal are also provided.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002673313A CA2673313A1 (en) | 2006-12-18 | 2007-12-18 | Virus-interacting layered phyllosilicates and methods of use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96653806P | 2006-12-18 | 2006-12-18 | |
US96653706P | 2006-12-18 | 2006-12-18 | |
US60/966,537 | 2006-12-18 | ||
US60/966,538 | 2006-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008147468A2 WO2008147468A2 (en) | 2008-12-04 |
WO2008147468A3 true WO2008147468A3 (en) | 2009-02-12 |
Family
ID=39951566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/087922 WO2008147468A2 (en) | 2006-12-18 | 2007-12-18 | Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use |
Country Status (2)
Country | Link |
---|---|
CA (1) | CA2673313A1 (en) |
WO (1) | WO2008147468A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100272769A1 (en) * | 2005-08-03 | 2010-10-28 | Amcol International | Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use |
EP3305305B1 (en) | 2007-10-15 | 2021-06-09 | HS Pharmaceuticals, LLC | Silicate containing compositions and methods of treatment |
NZ599839A (en) * | 2009-12-22 | 2014-02-28 | Marinomed Biotechnologie Gmbh | Synergistic antiviral composition and use thereof |
GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
CN116057158A (en) * | 2020-07-27 | 2023-05-02 | 联合利华知识产权控股有限公司 | Use of enzymes and surfactants for inhibiting microorganisms |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
WO2006110385A1 (en) * | 2005-04-07 | 2006-10-19 | The Procter & Gamble Company | Composition comprising zinc-containing layered material with a high relative zinc lability |
WO2007019250A1 (en) * | 2005-08-03 | 2007-02-15 | Amcol International Corporation | Virus-interacting layered phyllosilicates and methods of inactivating viruses |
-
2007
- 2007-12-18 WO PCT/US2007/087922 patent/WO2008147468A2/en active Application Filing
- 2007-12-18 CA CA002673313A patent/CA2673313A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
WO2006110385A1 (en) * | 2005-04-07 | 2006-10-19 | The Procter & Gamble Company | Composition comprising zinc-containing layered material with a high relative zinc lability |
WO2007019250A1 (en) * | 2005-08-03 | 2007-02-15 | Amcol International Corporation | Virus-interacting layered phyllosilicates and methods of inactivating viruses |
Non-Patent Citations (1)
Title |
---|
PIAZZOLLA P ET AL: "INFECTIVITY STUDIES ON CUCUMBER MOSAIC VIRUS TREATED WITH A CLAY MATERIAL", JOURNAL OF PHYTOPATHOLOGY (BERLIN), vol. 127, no. 4, 1989, pages 291 - 295, XP002504642, ISSN: 0931-1785 * |
Also Published As
Publication number | Publication date |
---|---|
CA2673313A1 (en) | 2008-12-04 |
WO2008147468A2 (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009110940A3 (en) | Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use | |
CL2008000404A1 (en) | CRYSTALINE SALT OF NAPADISYLATE 5- (2 - [[6- (2,2-DIFLUORO-2-PHENYLETOXI) HEXIL] AMINO] -1-HYDROXYETHYL) -8-HYDROXYQUINOLIN-2 (1H) -ONA; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF SICK DISEASES AS ASTHMA OR COPD. | |
WO2009105513A8 (en) | Novel compounds and methods for therapy | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
EP1865967A4 (en) | Compounds, compositions and methods for the treatment of viral infections and other medical disorders | |
WO2008113011A3 (en) | Virus like particle purification | |
IL199152A (en) | 2-(piperidin-4-yl)-4-phenoxy or phenylamino-pyrimidine derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for treatment of viral infections | |
WO2008133663A3 (en) | Codon modified immunogenic compositions and methods of use | |
WO2008136815A3 (en) | 5, 6-ring annulated indole derivatives and use thereof | |
EP3078377A3 (en) | Nitazoxanide and tizoxanide as anti-viral agents | |
IL187321A0 (en) | Host cell specific binding molecules capable of neutralizing viruses and uses thereof | |
IL194254A (en) | Compositions based on s-adenosyl methionine or nadh , process for their preparation and use thereof in the manufacture of medicaments for the treatment of depression | |
IL195272A0 (en) | Methods and compositions for the treatment of viral infections | |
WO2006074303A3 (en) | Delivery vehicles, bioactive substances and viral vaccines | |
WO2008120998A3 (en) | Acoustically sensitive drug delivery particles | |
WO2010047830A3 (en) | Agents for hcv treatment | |
IL178094A0 (en) | Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions | |
WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
SG10201501376XA (en) | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | |
CL2007003754A1 (en) | COMPOUNDS DERIVED FROM ARIL (HETEROARIL) ALQUIL-AMINA; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS BRONCHITIS, PULMONARY DISEASE AND COPD. | |
WO2008147468A3 (en) | Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use | |
WO2012061248A3 (en) | Novel specific hcv ns3 protease inhibitors | |
WO2009052090A3 (en) | Silicate containing compositions and methods of treatment | |
WO2008027551A3 (en) | Dendrimer compositions | |
WO2010041241A3 (en) | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2673313 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07875031 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07875031 Country of ref document: EP Kind code of ref document: A2 |